
|Articles|April 25, 2004
'Surgery' articles are notable by their absence
If you're looking for articles about urologic surgery in this issue ofUrology Times, you may be disappointed. The "leading newsmagazine forurologists" is still just that-an important source of news and informationfor individuals who practice what has always been a surgical specialty.But the articles in this issue's special "State of Urology" seriesclearly show that surgery-especially traditional open surgery-continuesto give way to drug therapy and minimally invasive procedures for managingmost common urologic conditions.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves capivasertib plus abiraterone and prednisone for PTEN-deficient mHSPC
2
Toni Choueiri, MD, reacts to FDA approval of adjuvant belzutifan with pembrolizumab for ccRCC
3
Dean Elterman, MD, highlights efficacy and safety data on the Zenflow Prostatic Spring
4
FDA approves adjuvant belzutifan with pembrolizumab for ccRCC
5











